CorMedix (CRMD) Gross Profit (2016 - 2025)
CorMedix (CRMD) has disclosed Gross Profit for 12 consecutive years, with $107.3 million as the latest value for Q4 2025.
- Quarterly Gross Profit rose 257.28% to $107.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $275.7 million through Dec 2025, up 584.54% year-over-year, with the annual reading at $275.7 million for FY2025, 584.54% up from the prior year.
- Gross Profit hit $107.3 million in Q4 2025 for CorMedix, up from $93.1 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $107.3 million in Q4 2025 to a low of -$818539.0 in Q1 2024.
- Historically, Gross Profit has averaged $19.8 million across 4 years, with a median of $28109.0 in 2021.
- Biggest five-year swings in Gross Profit: tumbled 127.47% in 2021 and later surged 12683.29% in 2025.
- Year by year, Gross Profit stood at $8390.0 in 2021, then skyrocketed by 249.18% to $29296.0 in 2022, then surged by 102421.64% to $30.0 million in 2024, then skyrocketed by 257.28% to $107.3 million in 2025.
- Business Quant data shows Gross Profit for CRMD at $107.3 million in Q4 2025, $93.1 million in Q3 2025, and $37.9 million in Q2 2025.